These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8643210)

  • 1. Effects of ACE inhibitors and calcium antagonists alone or combined on progression of diabetic nephropathy.
    Lash JP; Bakris GL
    Nephrol Dial Transplant; 1995 Oct; 10 Suppl 9():56-62. PubMed ID: 8643210
    [No Abstract]   [Full Text] [Related]  

  • 2. Approach to the treatment of diabetic nephropathy.
    Burke JM
    Pharm Pract Manag Q; 1997 Jul; 17(2):26-35. PubMed ID: 10168175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. To prevent progression: ACE inhibitors, calcium antagonists or both?
    Stefanski A; Amann K; Ritz E
    Nephrol Dial Transplant; 1995; 10(2):151-3. PubMed ID: 7753444
    [No Abstract]   [Full Text] [Related]  

  • 4. A perspective on converting enzyme inhibitors and calcium channel antagonists in diabetic renal disease.
    Valentino VA; Wilson MD; Weart W; Bakris GL
    Arch Intern Med; 1991 Dec; 151(12):2367-72. PubMed ID: 1746992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression of renal disease--can it be reversed? The role of calcium channel blockers and angiotensin-converting enzyme inhibitors.
    Boner G
    Isr J Med Sci; 1996 Dec; 32(12):1217-21. PubMed ID: 9007157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managing diabetic nephropathy: recent studies.
    Lit YZ; Meyer T
    Curr Opin Nephrol Hypertens; 2006 Mar; 15(2):111-6. PubMed ID: 16481875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers for prevention and treatment of nephropathy associated with type 2 diabetes mellitus.
    Hughes DB; Britton ML
    Pharmacotherapy; 2005 Nov; 25(11):1602-20. PubMed ID: 16232022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacological prevention and treatment of diabetic nephropathy].
    Aitio ML
    Duodecim; 1993; 109(6):503-11. PubMed ID: 8062718
    [No Abstract]   [Full Text] [Related]  

  • 9. The antiproteinuric effect of antihypertensive agents in diabetic nephropathy.
    Gansevoort RT; Apperloo AJ; Heeg JE; de Jong PE; de Zeeuw D
    Arch Intern Med; 1992 Oct; 152(10):2137-9. PubMed ID: 1417388
    [No Abstract]   [Full Text] [Related]  

  • 10. [Progression of chronic renal insufficiency and its prevention using angiotensin converting enzyme inhibitors and angiotensin antagonists].
    Tesar V
    Vnitr Lek; 2003 May; 49(5):365-9. PubMed ID: 12908169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Type 2 diabetes and nephropathy--new studies, new treatment strategies?].
    Os I; Stenehjem A; Høieggen A; Draganov B; Jenssen T; Holdaas H
    Tidsskr Nor Laegeforen; 2002 Apr; 122(9):918-20. PubMed ID: 12082835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of an ACE inhibitor combined with a calcium channel blocker on progression of diabetic nephropathy.
    Bakris G; White D
    J Hum Hypertens; 1997 Jan; 11(1):35-8. PubMed ID: 9111155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy of diabetic nephropathy].
    Barna I
    Orv Hetil; 2003 Jan; 144(4):165-72. PubMed ID: 12621814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic nephropathy: pathogenetic basis for treatment.
    Reasner CA; DeFronzo R
    Contemp Intern Med; 1994 Oct; 6(10):30-2, 35-40. PubMed ID: 10150289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetic nephropathy: common questions.
    Thorp ML
    Am Fam Physician; 2005 Jul; 72(1):96-9. PubMed ID: 16035688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of the patient with diabetes mellitus and risk of nephropathy: what do we know, and what do we need to learn?
    Hollenberg NK
    Arch Intern Med; 2004 Jan; 164(2):125-30. PubMed ID: 14744834
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapeutic effects of angiotensin II inhibition or blockade on the progression of chronic renal disease.
    Cantarovich F; Rangoonwala B
    Int J Clin Pract; 2003 Nov; 57(9):801-22. PubMed ID: 14686572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin converting enzyme inhibitors in perspective: an update.
    Burrell LM; Johnston CI
    Aust Fam Physician; 1993 Jul; 22(7):1243-7, 1251, 1255. PubMed ID: 8373316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treating diabetic nephropathy: unfinished success is not failure.
    Lewis J
    Clin J Am Soc Nephrol; 2007 May; 2(3):407-9. PubMed ID: 17699442
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hypertension in diabetes mellitus. Role of calcium antagonists in its treatment].
    Borrás M; Romero R
    Med Clin (Barc); 1992 Nov; 99(16):620-3. PubMed ID: 1460927
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.